Get started
TEMPUS AI INC CEDEAR EACH 12 REPR 1 ORDTEMPUS AI INC CEDEAR EACH 12 REPR 1 ORDTEMPUS AI INC CEDEAR EACH 12 REPR 1 ORD

TEMPUS AI INC CEDEAR EACH 12 REPR 1 ORD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals

TEM trade ideas

TEM Weekly Analysis Summary (2025-04-16)TEM Weekly Analysis Summary (2025-04-16) Below is a consolidated view of the reports along with areas where they agree and differ, followed by a clear trade idea. ────────────────────────── SUMMARY OF EACH MODEL’S KEY POINTS • Grok/xAI Report  – Notes that although the daily trend is bearish, the 5‑minute chart shows bullish signals (RSI rising, MACD crossed up, price above the 10‑EMA) and key short‐term support around $40.  – Recommends buying the $41.50 call (despite its premium being slightly above the “ideal” range) to capture an anticipated move toward the max pain at $44.50. • Claude/Anthropic Report  – Stresses that on daily timeframes price is in a strong downtrend with clear bearish momentum—but short‐term indicators (like a modestly improving 5‑minute RSI and MACD) suggest that downside may be softening.  – Leverages the heavy put open interest (especially at the $40.00 level) and overall support to recommend a bearish play by buying the $40.00 put. • Gemini/Google Report  – Emphasizes short‑term technicals: the 5‑minute charts show a bounce potential using RSI, MACD crossover, and positive news (partnership catalyst) combined with falling VIX.  – Recommends a moderately bullish, counter‑trend trade using the $42.50 call (ask ~$0.50) as a short‑term bounce play aiming to reach the $42+ area. • Llama/Meta Report  – Also lays out a mixed picture. Although the short‑term charts show hints of a rally, it notes the daily chart remains bearish.  – Leans toward a put option side (buying the $40.00 put) given the attractive premium and strong support at $40. • DeepSeek Report  – Finds that while the very short-term (5‑minute) indicators have begun to turn positive, the overall daily picture remains in distress and the max pain level is much higher.  – Concludes “no trade” is best until direction is clearer, though it does sketch alternate setups for either a call or put trade if forced. ────────────────────────── 2. AREAS OF AGREEMENT & DISAGREEMENT BETWEEN MODELS Agreements:  • All reports recognize that the current price is near crucial support around the $40 level.  • There is agreement that the 5‑minute charts are more bullish than the daily charts, which remain in a downtrend.  • Technical indicators (RSI, MACD on the intraday chart) hint at an intraday or end‑of‑day bounce even if the longer‑term bias is weak. Disagreements:  • Grok/xAI and Gemini/Google favor a short-term bullish/counter‑trend bounce via call options.  • Claude/Anthropic and Llama/Meta emphasize the dominant daily bearish structure and would favor a put option to capture further downside.  • DeepSeek remains on the sidelines overall—indicating that the signals are too mixed to pick a clear directional bias without further price confirmation. ────────────────────────── 3. CONCLUSION & RECOMMENDED TRADE Overall Market Direction Consensus:  While the overarching daily trend remains bearish, a number of models spot actionable short‑term bullish clues (rising 5‑minute RSI/MACD crossover, positive news catalyst, falling VIX) that suggest a possible intraday or early session bounce. With the price near strong support (~$40) and max pain at $44.50 offering a potential upward target by expiration, a short-term counter‑trend call trade is justified for the weekly options. Recommended Trade:  • Trade: Buy a single‑leg naked call option.  • Option: TEM $42.50 Call (Weekly expiry 2025‑04‑17)  • Premium: Ask is $0.50 – comfortably within our favored range.  • Rationale: The trade banks on a short‑term bounce off key $40 support with the expectation that positive technical momentum and catalyst news may lift the price toward the $42+ area. (While the daily trend is bearish, the intraday indicators and market news support a careful, short‑term bullish view.)  • Entry Timing: At open.  • Profit Target: Approximately $0.80, roughly a +60% move on the premium.  • Stop‑Loss: Set at $0.25 (~50% loss on premium) to limit risk.  • Confidence: About 65% given the conflicting longer‑term vs. short‑term signals.  • Key Risks/Considerations: Should the price fail to hold support near $40 or if intraday momentum reverses suddenly, the call trade will likely suffer. The inherent counter‑trend nature of the play means disciplined stop‑losses and risk management are essential. ────────────────────────── 4. TRADE_DETAILS (JSON Format) { "instrument": "TEM", "direction": "call", "strike": 42.5, "expiry": "2025-04-17", "confidence": 0.65, "profit_target": 0.80, "stop_loss": 0.25, "size": 1, "entry_price": 0.50, "entry_timing": "open" }
NASDAQ:TEMLong
by quantsignals
Tempus AI - LongTempus AI Technical picture: - Wyckoff: Large companies accumulation in the form of range with positive delta - Volume profite: at level of VAL - Formation: Channel multi-month - ATR: New monthly low band - Float: <100M = 78m, providing strong movement potential Fundamental picture - Revenue is growing with increasing rate - EPS is negative but loss is decreasing Upside: 50%-180% - Current price - 37 - Market is 55-64-74 (low-consensus-high) - TA high band is 92 (Resistance line) - Volume Profile - 67 Downside: 20% - Market - 55 - Volume profile - 30 Negative aspects: - Recent sales of stock by insiders but not significant Exta - Nensi Pelosi part of the investors
NASDAQ:TEMLong
by fondOrange28771
Tempus AI Possible Partner for the Stargate Project in the USAAnalysis of Possible Surge in Tempus AI Stock Due to Project Stargate Introduction Tempus AI, Inc. has emerged as a key player in the health technology space, leveraging data science and artificial intelligence (AI) to develop precision medicine solutions. The company's focus on oncology, cardiology, and mental health, combined with its strong data-driven approach, has positioned it as a leader in the emerging field of AI-enabled healthcare. A possible surge in Tempus AI’s stock price is now being speculated, due to its potential involvement in Project Stargate, a new initiative spearheaded by President Donald Trump. Project Stargate promises significant investments and infrastructure development in AI, which could catalyze a favorable growth trajectory for Tempus. This analysis will explore the potential impact of Project Stargate on Tempus AI, considering both the direct and indirect benefits for the company. Additionally, the mention of prominent political figures like Nancy Pelosi purchasing Tempus stock adds an interesting layer to the speculative nature of this surge. --- Project Stargate Overview Project Stargate, as outlined by former President Donald Trump, aims to overhaul AI infrastructure in the U.S. The initiative seeks to foster partnerships between technology firms, including AI-focused companies like OpenAI, and businesses involved in critical infrastructure, such as data centers, power generation, and construction. The project’s goal is to drive advancements in AI technology, with a specific focus on enhancing U.S. competitiveness in this rapidly growing field. The strategic involvement of multiple high-profile organizations and the federal government indicates that Project Stargate is likely to have wide-reaching economic and technological ramifications. Key elements of the project include: -Infrastructure Investments: The construction and expansion of AI-driven data centers and related infrastructure. - Public-Private Partnerships: Strong cooperation between private companies and government entities, facilitating new technologies and business models. - Technological Advancements: AI solutions that push the boundaries of healthcare, cybersecurity, and national security. As a result, companies involved in the development and deployment of AI technology, particularly those in healthcare and data analytics, are poised to benefit significantly. --- Tempus AI’s Position in Project Stargate Tempus AI operates at the intersection of healthcare and AI, which makes it an intriguing candidate to potentially benefit from Project Stargate. The company’s focus on precision medicine using AI-driven diagnostics aligns well with the ambitions of Project Stargate to expand AI infrastructure. 1. Synergies with Healthcare AI Project Stargate is expected to fuel demand for AI infrastructure and innovations, particularly in sectors like healthcare. Tempus, which specializes in oncology, cardiology, and depression diagnostics, stands to benefit from both the increased focus on AI-powered healthcare solutions and the additional resources available through government-private sector partnerships. Given Tempus’s reliance on large-scale data analysis to build its precision medicine solutions, any acceleration in AI infrastructure could lower operational costs for Tempus while improving the capabilities of its platform. Enhanced AI infrastructure would likely lead to faster data processing, increased diagnostic accuracy, and the potential for more personalized treatments. 2. Expansion of Partnerships and Funding The potential for public-private partnerships, which Project Stargate promotes, could help Tempus secure additional government contracts or private sector collaborations. This influx of capital and resources could enable the company to scale its technology faster and expand into new medical areas beyond its current focus on cancer, cardiology, and mental health. 3. Alignment with National AI Strategy With AI being a major focus of Project Stargate, Tempus may find itself well-positioned within the broader national AI strategy. If the company becomes a key partner in helping build AI solutions for healthcare or other sectors, it could solidify its reputation as an industry leader, driving up stock demand and valuation. --- Nancy Pelosi’s Stock Purchase: A Political Angle The mention of Nancy Pelosi, a prominent U.S. politician, purchasing Tempus AI stock adds a speculative element to the situation. Pelosi’s involvement in the stock could be seen as a potential signal of confidence in Tempus AI’s future performance. Politicians often make investment decisions based on inside knowledge of forthcoming legislation, partnerships, or government contracts. Though speculation about Pelosi’s investment could generate increased media attention, it should be approached with caution. However, if Pelosi’s investment is tied to a potential announcement of government support or strategic alignment between Tempus and Project Stargate, it could amplify investor confidence and trigger a buying frenzy. --- Potential Catalysts for Stock Surge Several factors could drive a surge in Tempus AI’s stock price if Project Stargate moves forward: -1. Government Contracts and Funding: If Tempus is awarded government contracts under Project Stargate, particularly related to AI infrastructure or healthcare solutions, the company could see a significant increase in revenue and market capitalization. -2. Partnerships with Major Players: Any announcement of Tempus AI partnering with companies like OpenAI or other stakeholders in Project Stargate would likely signal strong growth potential and increase investor interest. -3. ncreased Demand for AI Healthcare Solutions**: As the U.S. government prioritizes AI advancements, healthcare applications could see substantial growth. Tempus could be a key beneficiary of this shift, leading to a surge in its stock price as market expectations align with actual developments. -4. Political Endorsement: If high-profile political figures continue to signal support for Tempus AI, either through public statements or stock purchases, it could bolster public perception and attract institutional investors. --- Risks and Considerations While there is substantial upside potential for Tempus AI, there are also risks to consider: - Dependence on Project Stargate’s Success: Tempus’s growth will be closely tied to the success of Project Stargate and its integration into the broader national AI ecosystem. If the project faces delays or fails to meet expectations, it could have negative implications for companies like Tempus. - Regulatory Risks: The healthcare industry is heavily regulated, and any change in regulatory policies could impact Tempus’s ability to grow at the expected pace. While AI infrastructure investment may mitigate some challenges, government policies could still create obstacles. - Market Volatility: The stock market, particularly tech and healthcare stocks, is inherently volatile. Any unforeseen global events or shifts in economic conditions could negatively affect Tempus’s valuation, regardless of Project Stargate. --- Conclusion Tempus AI stands at an exciting intersection of AI technology and healthcare, which could see its stock price surge due to its involvement in Project Stargate. The initiative’s focus on building AI infrastructure and fostering partnerships could provide Tempus with opportunities for rapid growth, enhanced funding, and access to cutting-edge technology. The involvement of high-profile political figures such as Nancy Pelosi adds an additional layer of speculation, with the potential for both public perception and market sentiment to play a significant role in the stock’s trajectory. However, investors should consider the risks associated with regulatory changes, market volatility, and the uncertain success of Project Stargate itself. Ultimately, if Tempus AI is able to capitalize on these emerging opportunities, it could see a substantial boost in both market visibility and stock price in the near future. For any questions or remarks kindly react here under the comments Greetings, Zila
NASDAQ:TEMLong
by ZILATRADES
11
Buy the Dip: TEM is a Resilient AI Healthcare Pick for 2025Tempus AI NASDAQ:TEM is presenting a compelling investment opportunity as we move into 2025. This health tech company, focused on leveraging AI for precision medicine, has weathered a recent downturn and is showing strong signs of recovery. After a 4 week correction that presented a chance to buy at a discount, TEM has finally shown the ability to rally. This recovery makes it a particularly interesting prospect for several reasons: 1. AI's Continued Rise: The field of artificial intelligence is advancing at breakneck speed, and Tempus is at the forefront of applying these advancements to healthcare. Their work in areas like genomic sequencing and data analysis for personalized treatment plans positions them exceptionally well to capitalize on this megatrend. 2. Weathering the Political Storm: Tempus's core business is less vulnerable to possible tariffs that may be introduced by incoming President Trump. Healthcare, particularly innovative approaches to disease treatment, remains a critical sector regardless of the political landscape. Furthermore, Tempus' customers being mostly internal U.S. customers provides further resilience in the face of possible tariffs. 3. Technical Rebound: As the attached chart illustrates, TEM is in the midst of a technical bounce back. The recent price action suggests that the sell-off may be overdone, and the stock is finding support at current levels. The upward sloping support and resistance lines indicate a potential 40-80% gain if TEM can continue to show resilience in the face of selling pressure. The stock currently trades below it's 20 day EMA, but the recent rally shows that it could potentially find support along this average before continuing to trend upwards. In Conclusion: Tempus AI offers a unique combination of growth potential in a rapidly expanding sector, resilience to potential political headwinds, and a technically attractive entry point. While all investments carry risk, TEM's current profile suggests it's a stock worth serious consideration for gaining exposure to the intersection of AI and healthcare in 2025, especially at these highly discounted prices. Disclaimer: This is not financial advice. Conduct your own research before making any investment decisions. Remember, Patience is Paramount.
NASDAQ:TEMLong
by PatienceIsParamount
Is Nancy Pelosi about to RUG PULL $TEM - Tempus Ai?!NASDAQ:TEM : DIP BUYING OPP INCOMING? DIP BUY BOX: $70-$80 We are very extended after breaking out of previous resistance and into ATHs! We are slamming into the Red barrier, which typically brings much-needed pullbacks. This would build out our WCB and allow us to continue higher while staying within those confines. Also, need to flip previous resistance into support before we can continue higher in a healthy manner. We could just keep flying higher, but at that point, we would have a massive FLAG POLE, which would come down just as fast as it went up. Not financial advice
NASDAQ:TEMShort
by RonnieV29
1
TEM , Model name with exception of EPS/SALESHas 5 of 6 requirements for what I like to see but is lacking current EPS / SALES huge growth I like to see . That being said this is an example where price action can allow us this buy . Also helps that one of the equal weight top leading sectors is medical development right now . I am not long, ideal day to buy would be close above GLB on thurs or even Friday , but I am considering just buying opening range in morning , to get in ... Either way TEM key focus ... Positions taken or cut will be updated in comments for reference.
NASDAQ:TEM
by NAK1987
5
Tempus AI, Inc. (TEM) - Long Setup | 1H Chart AnalysisThe stock is currently in an uptrend within a rising channel (green lines), making higher highs and higher lows. Based on Elliott Wave theory, we appear to be in a corrective Wave 4 bouncing from a 1H FVG. A potential Wave 5 rally could be underway, targeting new highs near the upper channel boundary. Trade Plan: Entry: ~$66.84 Stop Loss: $64.00 (Below the demand zone & invalidation level) Take Profit Target: TP 4: $78.84 (4:1 RRR) "Trade what you see, not what you think." – Jesse Livermore Stick to your plan: Manage risk with stop loss placement and target levels. Disclaimer: This is for educational purposes only and not financial advice. Always conduct your own analysis and manage risk accordingly before trading.
NASDAQ:TEMLong
by MESHANL
2
Stock Of The Day / 02.11.25 / TEM02.11.2025 / NASDAQ:TEM Fundamentals. Neutral news background. Technical analysis. Daily chart: The price is near the upper limit of a wide range. The level 78.00 formed by a trend break in November 2024 is ahead. Premarket: A slight decline on moderate volume. We mark the premarket high at 69.00. Trading session: We observe a sharp, almost non-pullback impulse on the opening of the trading session, which was stopped at the level of 78.00. We are considering a short trade in case of an unsuccessful attempt to breakout 78.00 due to the fact that the price approached a strong daily level very sharply on large candles and passed 1.7 ATR. Trading scenario: false breakout with retest of level 78.00 Entry: 76.82 after unsuccessful attempt of breakout, pullback and retest. Stop: 78.21 we hide it behind the high of the retest. Exit: Close part of the position before premarket high level of 69.00. Close the rest part of the position around 69.22 when reversal candlestick pattern appears. Risk Rewards: 1/5 P.S. In order to understand the idea behind the Stock Of The Day analysis, read the following information .
NASDAQ:TEMShort
by AlexX31